Discontinuing GLP-1 Drugs Rapidly Reverses Cardiovascular Benefits
In recent years, GLP-1 receptor agonists such as semaglutide and tirzepatide have surged in popularity, widely prescribed for type 2 ...
Tag: major adverse cardiovascular events in diabetes
Combination of GLP-1 Medications and Healthy Lifestyle Habits Reduces Cardiovascular Risk in Diabetes Patients
In a groundbreaking new study published in The Lancet Diabetes & Endocrinology, researchers from Harvard T.H. Chan School of Public ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!